Case report demonstrates reversible facial hyperpigmentation in a breastfed infant following maternal clofazimine use, highlighting the benign, transient nature of breast milk transfer.
Figure 2: Marked resolution of facial hyperpigmentation following discontinuation of maternal clofazimine therapy after 3 months, supporting the diagnosis of transient clofazimine-induced pigmentation in the infant.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: